Q4 2025 · 13F-HR
BRAIDWELL LPholdings as filed
Filed 2026-02-17 · accession 0001420506-26-000586
$3.13B
Reported value
73
Positions
2025-12-31
Period end
The Brief · BRAIDWELL LP · Q4 2025
AI · grounded in 13F
BRAIDWELL LP closed its position in [[stock:NVCR 0 11/01/25]] for a reduction of $210.04M. The fund established new positions in KOD for $57.96M, CNTA for $54.73M, and BTSG for $44.78M. Additionally, the fund trimmed its holdings in KRYS by 61.16% and [[stock:GH 1.25 02/15/31]] by 52.22%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 142152107 | CAI | CARIS LIFE SCIENCES INC | $210.9M | 6.74% | 7,816,142 | Common | SOLE |
| 40131MAD1 | GH 1.25 02/15/31 | GUARDANT HEALTH INC | $192.3M | 6.15% | 104,854,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $129.3M | 4.14% | 5,210,831 | Common | SOLE |
| 759916AD1 | RGEN 1 12/15/28 | REPLIGEN CORP | $110.8M | 3.54% | 101,000,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $106.6M | 3.41% | 751,534 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $104.1M | 3.33% | 921,979 | Common | SOLE |
| 64049MAB6 | NEO 0.25 01/15/28 | NEOGENOMICS INC | $89.7M | 2.87% | 100,381,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $82.6M | 2.64% | 821,406 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $81.8M | 2.62% | 1,825,076 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $77.7M | 2.48% | 1,870,571 | Common | SOLE |
| 450056AB2 | IRTC 1.5 09/01/29 | IRHYTHM TECHNOLOGIES INC | $72.8M | 2.33% | 52,000,000 | Common | SOLE |
| 433313103 | HNGE | HINGE HEALTH INC | $60.6M | 1.94% | 1,304,623 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $59.5M | 1.90% | 381,004 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $58.0M | 1.85% | 2,072,788 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $55.0M | 1.76% | 1,187,859 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $54.7M | 1.75% | 2,188,320 | Common | SOLE |
| 64049M209 | NEO | NEOGENOMICS INC | $54.5M | 1.74% | 4,632,801 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $54.3M | 1.74% | 2,032,021 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $53.5M | 1.71% | 1,634,615 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $52.5M | 1.68% | 1,273,935 | Common | SOLE |
| 46333XAH1 | IRWD 1.5 06/15/26 | IRONWOOD PHARMACEUTICALS INC | $50.5M | 1.61% | 53,405,000 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $50.5M | 1.61% | 1,858,109 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $49.9M | 1.60% | 540,890 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $49.8M | 1.59% | 202,101 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $47.2M | 1.51% | 83,417 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $46.8M | 1.50% | 80,725 | Common | SOLE |
| 10950A106 | BTSG | BRIGHTSPRING HEALTH SVCS INC | $44.8M | 1.43% | 1,195,786 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $44.8M | 1.43% | 564,200 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $43.4M | 1.39% | 575,067 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $41.4M | 1.32% | 2,183,864 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $39.7M | 1.27% | 784,742 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $38.6M | 1.23% | 217,345 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $38.4M | 1.23% | 315,341 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $35.7M | 1.14% | 601,520 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $35.4M | 1.13% | 269,673 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $35.3M | 1.13% | 454,259 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $34.6M | 1.11% | 3,061,222 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $34.2M | 1.10% | 110,152 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $32.1M | 1.03% | 1,018,600 | Common | SOLE |
| 75382E208 | RAPT | RAPT THERAPEUTICS INC | $31.5M | 1.01% | 929,694 | Common | SOLE |
| 14167L103 | CDNA | CAREDX INC | $29.9M | 0.96% | 1,585,220 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $28.9M | 0.92% | 1,478,329 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $28.3M | 0.90% | 3,131,319 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $28.2M | 0.90% | 1,298,142 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS I | $27.1M | 0.87% | 8,353,287 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $27.1M | 0.87% | 118,227 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $26.1M | 0.83% | 31,007 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $25.5M | 0.82% | 111,500 | Common | SOLE |
| 10919W405 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $25.3M | 0.81% | 324,358 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $23.2M | 0.74% | 575,321 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $20.6M | 0.66% | 3,105,209 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $20.4M | 0.65% | 115,700 | Common | SOLE |
| 68752L100 | KIDS | ORTHOPEDIATRICS CORP | $19.5M | 0.62% | 1,100,370 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $19.3M | 0.62% | 927,524 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $17.3M | 0.55% | 1,920,255 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $16.7M | 0.53% | 3,180,389 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $15.0M | 0.48% | 2,786,778 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $14.9M | 0.48% | 948,316 | Common | SOLE |
| 415858109 | HROW | HARROW INC | $14.5M | 0.46% | 295,291 | Common | SOLE |
| 98420X202 | XFOR | X4 PHARMACEUTICALS INC | $13.5M | 0.43% | 3,368,904 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $13.4M | 0.43% | 81,790 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $13.4M | 0.43% | 73,370 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $12.9M | 0.41% | 313,823 | Common | SOLE |
| 384747101 | GRAL | GRAIL INC | $12.2M | 0.39% | 142,755 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $10.6M | 0.34% | 470,000 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $7.6M | 0.24% | 1,582,257 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $7.0M | 0.22% | 459,166 | Common | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $6.9M | 0.22% | 177,183 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $5.1M | 0.16% | 311,991 | Common | SOLE |
| 090168105 | BLLN | BILLIONTOONE INC | $4.1M | 0.13% | 50,000 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $2.6M | 0.08% | 84,795 | Common | SOLE |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $2.2M | 0.07% | 303,370 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $1.7M | 0.05% | 752,541 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.